| scholarly article | Q13442814 |
| P2093 | author name string | Cohen RA | |
| Verbeuren TJ | |||
| Rupin A | |||
| Sansilvestri-Morel P | |||
| Wierzbicki M | |||
| Boussard MF | |||
| Cayatte AJ | |||
| Maitland K | |||
| Oliver-Krasinski J | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell adhesion | Q187640 |
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 1577-1584 | |
| P577 | publication date | 2001-10-01 | |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | S17834, a new inhibitor of cell adhesion and atherosclerosis that targets nadph oxidase | |
| P478 | volume | 21 |
| Q28591122 | AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice |
| Q35925980 | Activation of thromboxane receptor modulates interleukin-1β-induced monocyte adhesion--a novel role of Nox1. |
| Q38257747 | Advances and strategies in NADPH oxidase inhibitors and activators patents |
| Q28394560 | Bridged tetrahydroisoquinolines as selective NADPH oxidase 2 (Nox2) inhibitors |
| Q26751153 | Cerebral Small Vessel Disease: Targeting Oxidative Stress as a Novel Therapeutic Strategy? |
| Q35992729 | Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets |
| Q38132120 | Current status of NADPH oxidase research in cardiovascular pharmacology |
| Q46323337 | Direct Activation of NADPH Oxidase 2 by 2-Deoxyribose-1-Phosphate Triggers Nuclear Factor Kappa B-Dependent Angiogenesis. |
| Q41981197 | Effects of alpha-lipoic acid on endothelial function in aged diabetic and high-fat fed rats. |
| Q26861119 | Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target Engagement |
| Q39645010 | First in Class, Potent, and Orally Bioavailable NADPH Oxidase Isoform 4 (Nox4) Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis |
| Q41895962 | From ST segments to endothelial pathophysiology: hypercholesterolemia and endothelial superoxide production |
| Q35201394 | High-fat diet increases and the polyphenol, S17834, decreases acetylation of the sirtuin-1-dependent lysine-382 on p53 and apoptotic signaling in atherosclerotic lesion-prone aortic endothelium of normal mice |
| Q41480230 | In vivo imaging of leukocyte recruitment to the atheroprone femoral artery reveals anti-inflammatory effects of rosuvastatin |
| Q43074613 | Inhibition of human vascular NADPH oxidase by apocynin derived oligophenols |
| Q44477930 | Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease |
| Q46552044 | Mechanisms for suppressing NADPH oxidase in the vascular wall |
| Q39169210 | Microvascular NADPH oxidase in health and disease. |
| Q36617730 | Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition. |
| Q39496194 | NADPH Oxidase as a Therapeutic Target for Neuroprotection against Ischaemic Stroke: Future Perspectives. |
| Q27014373 | NADPH oxidase as a therapeutic target for oxalate induced injury in kidneys |
| Q26859140 | NADPH oxidase in stroke and cerebrovascular disease |
| Q26821775 | NADPH oxidase inhibitors: a decade of discovery from Nox2ds to HTS |
| Q37873495 | NADPH oxidase inhibitors: a patent review |
| Q90576094 | NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets |
| Q33632089 | NADPH oxidases in vascular pathology |
| Q37176104 | NOX enzymes as novel targets for drug development |
| Q35375986 | NOX1, 2, 4, 5: counting out oxidative stress |
| Q33649852 | Novel role of NADPH oxidase in angiogenesis and stem/progenitor cell function. |
| Q35824748 | Nox Inhibitors & Therapies: Rational Design of Peptidic and Small Molecule Inhibitors |
| Q42177157 | Nox4- and Nox2-dependent oxidant production is required for VEGF-induced SERCA cysteine-674 S-glutathiolation and endothelial cell migration |
| Q39737681 | Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite |
| Q37270961 | Oxidative stress in prehypertension: rationale for antioxidant clinical trials |
| Q38165049 | Pathogenesis of chronic cardiorenal syndrome: is there a role for oxidative stress? |
| Q36972415 | Pharmacological Strategies to Retard Cardiovascular Aging |
| Q36346487 | Pharmacological basis of different targets for the treatment of atherosclerosis. |
| Q28392484 | Redox regulation of endothelial cell fate |
| Q35738096 | Redox signaling at invasive microdomains in cancer cells. |
| Q89658090 | Small Vessel Disease-Related Dementia: An Invalid Neurovascular Coupling? |
| Q33669214 | Small-Molecule Inhibitors of NADPH Oxidase 4 |
| Q35888581 | Suppression of oxidative stress in the endothelium and vascular wall |
| Q40696345 | TNF-alpha -induced endothelial cell adhesion molecule expression is cytochrome P-450 monooxygenase dependent |
| Q26863500 | Targeting NADPH oxidases in vascular pharmacology |
| Q38018554 | The NADPH oxidase family and its inhibitors. |
| Q38464231 | The human Nox4: gene, structure, physiological function and pathological significance |
| Q35967120 | The polyphenols resveratrol and S17834 prevent the structural and functional sequelae of diet-induced metabolic heart disease in mice. |
| Q33632757 | The quest for selective nox inhibitors and therapeutics: challenges, triumphs and pitfalls |
| Q30824712 | The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases |
| Q30010181 | Trimer hydroxylated quinone derived from apocynin targets cysteine residues of p47phox preventing the activation of human vascular NADPH oxidase |
| Q46861646 | Tumor necrosis factor-α-induced nuclear factor-kappaB activation in human cardiomyocytes is mediated by NADPH oxidase |
| Q38205041 | Understanding the biology of reactive oxygen species and their link to cancer: NADPH oxidases as novel pharmacological targets. |
| Q34479731 | Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease |
Search more.